Very early researchStudy completedNCT04340050What this trial is testingCOVID-19 Convalescent PlasmaWho this might be right forCoronavirus University of Chicago 10
Early research (Phase 1)WithdrawnNCT01152658What this trial is testingPartial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF)Who this might be right forPartial Supraspinatus Tear Meir Medical Center
Early research (Phase 1)UnknownNCT04462848What this trial is testingCovid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical ConditionsWho this might be right forCorona Virus Infection University of California, Los Angeles 30
Large-scale testing (Phase 3)Study completedNCT02572817What this trial is testingComparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza AWho this might be right forInfluenza A Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 138
Not applicableStudy completedNCT04545047What this trial is testingObservational Study of Convalescent Plasma for Treatment of Veterans With COVID-19Who this might be right forCoronavirus Disease 2019 (COVID-19) VA Office of Research and Development 5,044
Early research (Phase 1)Study completedNCT01777243What this trial is testingEvaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic AmyloidosisWho this might be right forAmyloidosis GlaxoSmithKline 25
Not applicableStudy completedNCT01365208What this trial is testingNew Approach of Assessing Drug Response for Treatment of Nasopharyngeal CancerWho this might be right forAdvanced Nasopharyngeal Carcinoma Chinese University of Hong Kong 70
Not applicableStudy completedNCT03114514What this trial is testingEfficacy of Platelet-rich Plasma (PRP) in the Treatment of Dark Circles Under the EyesWho this might be right forPeriorbital Hyperpigmentation Damascus University 40
Not applicableStudy completedNCT04027738What this trial is testingA Single Intraarticular Injection of PRP for Early Knee OAWho this might be right forKnee Osteoarthritis Kaohsiung Veterans General Hospital. 41
Early research (Phase 1)Ended earlyNCT00857571What this trial is testingA Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.Who this might be right forHealthy Pfizer 12
Not applicableLooking for participantsNCT06082284What this trial is testingA Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.Who this might be right forMultiple MyelomaM Protein Zhujiang Hospital 10,000
Not applicableUnknownNCT06109233What this trial is testingA Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial TreatmentWho this might be right forMultiple MyelomaMinimal Residual Disease FengYan Jin 80
Early research (Phase 1)Study completedNCT04710407What this trial is testingStudy to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking VolunteersWho this might be right forHealthy Volunteers Spero Therapeutics 30
Post-approval studies (Phase 4)WithdrawnNCT01923909What this trial is testingIntraarticular Platelet-rich Plasma Injections Versus Corticosteroid Injections in Primary Knee OsteoarthritisWho this might be right forOsteoarthritis King Hamad University Hospital, Bahrain
Not applicableEnded earlyNCT01962636What this trial is testingUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological DiseasesWho this might be right forAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Chronic Myelogenous Leukemia+15 more Masonic Cancer Center, University of Minnesota 200
Testing effectiveness (Phase 2)Study completedNCT01936532What this trial is testingSafety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)Who this might be right forNewly Diagnosed Multiple Myeloma Nantes University Hospital 42
Not applicableNot Yet RecruitingNCT07564128What this trial is testingInfection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in ItalyWho this might be right forMultiple Mieloma Gruppo Italiano Malattie EMatologiche dell'Adulto 50
Not applicableStudy completedNCT02474563What this trial is testingObservational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Korea, Ltd., Korea 171
Testing effectiveness (Phase 2)Study completedNCT00410657What this trial is testingAlemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Looking for participantsNCT06356571What this trial is testingInvestigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaWho this might be right forPlasma Cell Myeloma Refractory Sanofi 64